Vioxx Deal Holds Up Even After Appeals Wins: Experts

By Ron Zapata · May 30, 2008, 12:00 AM EDT

Merck & Co Inc. crafted its $4.85 billion Vioxx settlement despite winning 12 of 17 jury verdicts over the painkiller. Although appeals courts have recently overturned two of those verdicts, lowered...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Ron

February 09, 2009
Life Sciences Practice: Reed Smith
June 26, 2008
Exxon Ruling Will Drill Punitive Awards: Experts
June 23, 2008
Judge Closes Merck Derivative Suit Over Vioxx
June 16, 2008
Fed. Circuit Boots Fee Award Back To Lower Court
June 03, 2008
Cephalon Sues Watson To Block Generic Fentora
June 02, 2008
No IP Info For Protonix Antitrust Plaintiffs: Judge
June 02, 2008
Misconduct Testimony Allowed In Pfizer Age Bias Suit
May 29, 2008
Two Courts Overturn Vioxx Rulings Against Merck
May 28, 2008
Australian Court Upholds Pfizer's Lipitor Patent
May 28, 2008
AstraZeneca Sues Barr Over Crohn's Disease Drug